Evidence map›Paper›PMID 35814752›Full record

ArticleFrontiers in medicine2022

Individuals With Higher CD4/CD8 Ratio Exhibit Increased Risk of Acute Respiratory Distress Syndrome and In-Hospital Mortality During Acute SARS-CoV-2 Infection.

Ana Pascual-Dapena, Juan José Chillaron, Gemma Llauradó, Isabel Arnau-Barres, Juana Flores, Inmaculada Lopez-Montesinos, Luisa Sorlí, Juan Luis Martínez-Pérez, Silvia Gómez-Zorrilla, Juan Du and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Ana Pascual-DapenaMedicine and Life Sciences Department, Pompeu Fabra University, Barcelona, Spain.
Juan José ChillaronEndocrinology Department, Hospital del Mar Institute of Medical Research, Barcelona, Spain.
Gemma LlauradóEndocrinology Department, Hospital del Mar Institute of Medical Research, Barcelona, Spain.
Isabel Arnau-BarresGeriatrics Department, Hospital del Mar Institute of Medical Research, Barcelona, Spain.
Juana FloresEndocrinology Department, Hospital del Mar Institute of Medical Research, Barcelona, Spain.
Inmaculada Lopez-MontesinosInfectious Diseases Department, Hospital del Mar Institute of Medical Research, Barcelona, Spain.
Luisa SorlíInfectious Diseases Department, Hospital del Mar Institute of Medical Research, Barcelona, Spain.
Juan Luis Martínez-PérezMedicine and Life Sciences Department, Pompeu Fabra University, Barcelona, Spain.
Silvia Gómez-ZorrillaInfectious Diseases Department, Hospital del Mar Institute of Medical Research, Barcelona, Spain.
Juan DuInfectious Diseases Department, Hospital del Mar Institute of Medical Research, Barcelona, Spain.
Natalia García-GiraltInfectious Diseases Department, Hospital del Mar Institute of Medical Research, Barcelona, Spain.
Robert Güerri-FernándezMedicine and Life Sciences Department, Pompeu Fabra University, Barcelona, Spain.
Hospital Del Mar · ESInstituto de Salud Carlos III · ESPompeu Fabra University · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: CD4/CD8 ratio has been used as a quantitative prognostic risk factor in patients with viral infections. This study aims to assess the association between in-hospital mortality and at admission CD4/CD8 ratio among individuals with acute SARS-CoV-2 infection. Methods: This is a longitudinal cohort study with data of all consecutive patients admitted to the COVID-19 unit at Hospital del Mar, Barcelona, Spain for ≥48 h between March to May 2020. The CD4+ CD8+ T-cell subset differentiation was assessed by flow cytometry at admission as well as a complete blood test. Patients were classified according to CD4/CD8 ratio tertiles. The primary outcome was in-hospital mortality and the secondary outcome was acute respiratory distress (ARDS). Results: A total of 338 patients were included in the cohort. A high CD4/CD8 ratio (third tertile) was associated with a higher in-hospital mortality [adjusted Cox model hazard ratio (HR) 4.68 (95%CI 1.56-14.04, Conclusion: CD4/CD8 ratio is a prognostic factor for the severity of COVID-19, reflecting the negative impact on prognosis of those individuals whose immune response has abnormal CD8+ T-cell expansion during the early response to the infection.

Indexed as

ARDSCD4/CD8 ratiomortalityprognoseSARS-CoV-2

Identifiers

PMID35814752
PMCPMC9260079
OpenAlexW4283328345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.